Mahomed, S., Seaton, K. E., Paez, C. A., Yu, C., Gillespie, K., Karuna, S. T., … Kelley, C. (2024). Phase 1 dose-escalation trial to evaluate the safety, tolerability, pharmacokinetics and neutralization activity of PGDM1400LS in combination with VRC07-523LS and PGT121.414.LS in healthy participants without HIV (HVTN 140/HPTN 101). In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 27).

Mahomed, S., K. E. Seaton, C. A. Paez, C. Yu, K. Gillespie, S. T. Karuna, T. Gamble, et al. “Phase 1 dose-escalation trial to evaluate the safety, tolerability, pharmacokinetics and neutralization activity of PGDM1400LS in combination with VRC07-523LS and PGT121.414.LS in healthy participants without HIV (HVTN 140/HPTN 101).” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Vol. 27, 2024.

Mahomed S, Seaton KE, Paez CA, Yu C, Gillespie K, Karuna ST, et al. Phase 1 dose-escalation trial to evaluate the safety, tolerability, pharmacokinetics and neutralization activity of PGDM1400LS in combination with VRC07-523LS and PGT121.414.LS in healthy participants without HIV (HVTN 140/HPTN 101). In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2024.

Mahomed, S., et al. “Phase 1 dose-escalation trial to evaluate the safety, tolerability, pharmacokinetics and neutralization activity of PGDM1400LS in combination with VRC07-523LS and PGT121.414.LS in healthy participants without HIV (HVTN 140/HPTN 101).” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 27, 2024.

Mahomed S, Seaton KE, Paez CA, Yu C, Gillespie K, Karuna ST, Gamble T, Heptinstall J, Zhang L, Gao F, Yacovone M, Spiegel H, Dumond J, Anderson M, Piwowar-Manning E, Dye B, Tindale I, Proulx-Burns L, Trahey M, Takuva S, Takalani A, Bailey VC, Kalams S, Scott H, Kosgei J, Delany-Moretlwe S, Kassim S, Laher F, Chirenje ZM, Musodza Y, Mhlanga F, Mkhize N, Weiner J, Ackerman M, McElrath MJ, Pensiero M, Gama L, Barouch DH, Montefiori D, Tomaras GD, Corey L, Cohen M, Huang Y, Siegel M, Kelley C. Phase 1 dose-escalation trial to evaluate the safety, tolerability, pharmacokinetics and neutralization activity of PGDM1400LS in combination with VRC07-523LS and PGT121.414.LS in healthy participants without HIV (HVTN 140/HPTN 101). JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2024.